Publications:66
Accepting New Patients
Mount Sinai DoctorsTreats Adults
Accepting New PatientsMeena B Bansal, MD
Gastroenterology
Book an Appointment
About Me
Dr. Bansal has been on faculty at Mount Sinai since 2001. In addition to maintaining an NIH funded research program focused on molecular mechanism of liver fibrosis with seminal contributions to our understanding of liver fibrosis in people living with HIV, Dr. Bansal held many different leadership roles at Mount Sinai, including Transplant Hepatology Fellowship Director, Director of Translational Research, Medical Director of Hospital-Based Clinics, Chief Medical Officer of Mount Sinai Care, LLC, Deputy Chief Medical Officer for Mount Sinai Health Partners, and Vice President of Population Health for Quality and Efficiency. In these latter roles, she helped generate increased quality dollars in value-based contracts, created Mount Sinai’s first ambulatory pharmacy program, addressed broad population health needs, and gained knowledge about payer relations in an ever-changing health care landscape.
From a Clinical Perspective, she is currently focused on the treatment and management for those with Metabolic Dysfunction Associated Steatohepatitis (MASH), formerly known as Non-alcoholic steatohepatits (NASH). She has served as the principal investigator for numerous clinical trials for MASH/NASH and has been greatly involved with bringing new therapeutics to patients.
At the international/national levels, she held the position of Secretary for the American Association for the Study of Liver and currently serves as the Director of thenewly formed MASLD/MASH (NAFLD/NASH) Center of Excellence at Mount Sinai.
Most recently, in January 2024, Dr. Bansal was named System Chief, Division of Liver Diseases for the Mount Sinai Health System.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West
Research Topics
AIDS/HIV, Cell Biology, Chemokines, Fibrosis, Hepatitis C Virus, Knockout Mice, Molecular Biology, Regeneration, Transcription Factors, Transcriptional Activation and Repression, Viruses and Virology
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Disease Mechanisms and Therapeutics (DMT)
About Me
Dr. Bansal has been on faculty at Mount Sinai since 2001. In addition to maintaining an NIH funded research program focused on molecular mechanism of liver fibrosis with seminal contributions to our understanding of liver fibrosis in people living with HIV, Dr. Bansal held many different leadership roles at Mount Sinai, including Transplant Hepatology Fellowship Director, Director of Translational Research, Medical Director of Hospital-Based Clinics, Chief Medical Officer of Mount Sinai Care, LLC, Deputy Chief Medical Officer for Mount Sinai Health Partners, and Vice President of Population Health for Quality and Efficiency. In these latter roles, she helped generate increased quality dollars in value-based contracts, created Mount Sinai’s first ambulatory pharmacy program, addressed broad population health needs, and gained knowledge about payer relations in an ever-changing health care landscape.
From a Clinical Perspective, she is currently focused on the treatment and management for those with Metabolic Dysfunction Associated Steatohepatitis (MASH), formerly known as Non-alcoholic steatohepatits (NASH). She has served as the principal investigator for numerous clinical trials for MASH/NASH and has been greatly involved with bringing new therapeutics to patients.
At the international/national levels, she held the position of Secretary for the American Association for the Study of Liver and currently serves as the Director of thenewly formed MASLD/MASH (NAFLD/NASH) Center of Excellence at Mount Sinai.
Most recently, in January 2024, Dr. Bansal was named System Chief, Division of Liver Diseases for the Mount Sinai Health System.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West
Research Topics
AIDS/HIV, Cell Biology, Chemokines, Fibrosis, Hepatitis C Virus, Knockout Mice, Molecular Biology, Regeneration, Transcription Factors, Transcriptional Activation and Repression, Viruses and Virology
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Disease Mechanisms and Therapeutics (DMT)
Clinical Focus
- Abnormal Liver Enzymes
- Alcoholic Liver Disease
- Autoimmune Liver Disease
- Bile Duct Diseases
- Cholecystitis
- Chronic Liver Disease
- Cirrhosis
- Fatty Liver Disease
- Gallbladder Polyp
Show More
Education
AB, Harvard University
MD, Cornell University Medical College
MD, Weill Medical College of Cornell University
, The New York Hospital-Cornell Medical Center
Residency, Internal Medicine
New York Presbyterian Hospital-Weill Cornell Center
Fellowship, Gastroenterology
Hospital of the University of Pennsylvania
Certifications
Am Bd of Obesity Medicine
American Board of Internal Medicine
Awards
2022
Achievement Awardee at American Association of Physicians of Indian Origin (AAPI-Queens/LI) Annual Gala
2019
Achievement Honoree at RANA (Rajasthan Association of North America) Annual Awards Gala
2006
Dr. Harold and Golden Lamport Research Award
Regal Awards: Research Excellence in GI and Liver
2001
First Prize
Komarov Competition-Basic Science. Philadelphia, Pennsylvania
1997
David E. Rogers Memorial Prize
The New York Hospital-Cornell University Medical College
1997
C. Richard Bowman Memorial Award
The New York Hospital-Cornell University Medical College
Miles and Shirley Fiterman Basic Research Award
American Gastroenterological Association
Research
Specific Clinical/Research Interests: Role of chemokine receptors, CXCR4 and CCR5, on stellate cell biology and fibrogenesis; molecular regulation of hepatic fibrosis and regeneration
Current Students: Yedidya Saiman
Postdoctoral Fellows: Ana Tuyama; Ritu Agarwal
Research Personnel: Feng Hong
Summary of Research Studies:
Brief Biosketch and Research Interests Dr. Bansal joined the faculty at Mount Sinai in 2001 after completing Gastroenterology Fellowship at the University of Pennsylvania. In 2002 she became the Hepatology Fellowship Director, leading one of the largest hepatology fellowships in the United States. While remaining clinically active, she has also developed an NIH-funded basic research program focusing on understanding underlying molecular mechanisms of liver fibrosis/cirrhosis in an effort to develop novel anti-fibrotic therapies. Her research interests focus on the role of Matrix Metalloproteinase-2 in liver fibrosis and regeneration and Role of the chemokine receptors, CXCR4 and CCR5, on stellate cell biology and fibrogenesis. The latter has great implications in understanding mechanism of HCV- and HIV/HCV-induced liver disease.
Current Students: Yedidya Saiman
Postdoctoral Fellows: Ana Tuyama; Ritu Agarwal
Research Personnel: Feng Hong
Summary of Research Studies:
Brief Biosketch and Research Interests Dr. Bansal joined the faculty at Mount Sinai in 2001 after completing Gastroenterology Fellowship at the University of Pennsylvania. In 2002 she became the Hepatology Fellowship Director, leading one of the largest hepatology fellowships in the United States. While remaining clinically active, she has also developed an NIH-funded basic research program focusing on understanding underlying molecular mechanisms of liver fibrosis/cirrhosis in an effort to develop novel anti-fibrotic therapies. Her research interests focus on the role of Matrix Metalloproteinase-2 in liver fibrosis and regeneration and Role of the chemokine receptors, CXCR4 and CCR5, on stellate cell biology and fibrogenesis. The latter has great implications in understanding mechanism of HCV- and HIV/HCV-induced liver disease.
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Institute for Liver Medicine17 East 102nd Street, 8th Floor, New York, NY, 10029
- Institute for Liver Medicine10 Union Square East, Suite 2G, New York, NY, 10583
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Trans-ancestral rare variant association study with machine learning-based phenotyping for metabolic dysfunction-associated steatotic liver disease. Robert Chen, Ben Omega Petrazzini, Áine Duffy, Ghislain Rocheleau, Daniel Jordan, Meena Bansal, Ron Do. Genome Biology
- Heavy metals are liver fibrosis risk factors in people without traditional liver disease etiologies. Ning Ma, Meena B. Bansal, Jaime Chu, Mark Woodward, Andrea D. Branch. Journal of Environmental Sciences (China)
- Mixture analysis of associations between environmental and workplace toxins and liver damage and telomere length, stratified by race/ethnicity. Ning Ma, Rowena Yip, Mark Woodward, Sara Lewis, Michael Crane, Artit Jirapatnakul, Costica Aloman, Meena B. Bansal, Douglas Dieterich, Louis Gros, Damaskini Valvi, Elena Colicino, David Yankelevitz, Claudia Henschke, Andrea D. Branch. Journal of Environmental Sciences (China)
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Bansal during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Boston Pharma
- Merck Pharmaceuticals
- Boehringer Ingelheim, Ltd.
- Surrozen
- CurveBiosciences
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Bansal during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Boston Pharma
- Merck Pharmaceuticals
- Boehringer Ingelheim, Ltd.
- Surrozen
- CurveBiosciences
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.